<DOC>
	<DOCNO>NCT00899080</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research study look blood sample patient multiple myeloma treat thalidomide lenalidomide .</brief_summary>
	<brief_title>Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide Lenalidomide</brief_title>
	<detailed_description>OBJECTIVES : Primary - To analyze mechanism development thalidomide/lenalidomide-induced venous thromboembolism ( VTE ) patient multiple myeloma treat clinical trial ECOG-E4A03 E-E1A00 . - To determine intensity , dynamic , specificity cathepsin G ( CG ) upregulation response thalidomide lenalidomide treatment . - To determine specificity threshold level CG induction platelet aggregation response thalidomide lenalidomide result risk VTE development . OUTLINE : Blood sample obtain , , treatment thalidomide lenalidomide patient previously enrol clinical trial ECOG-E4A03 E-E1A00 analyze determine total content cathepsin G ( CG ) via ELISA ; determine mRNA level CG via RT-PCR ; platelet aggregation study . Blood sample collect healthy volunteer platelet preparation .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Plasmacytoma</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion : Diagnosed multiple myeloma treat thalidomide lenalidomide clinical trial ECOGE4A03 EE1A00 Healthy volunteer PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>stage I multiple myeloma</keyword>
	<keyword>stage II multiple myeloma</keyword>
	<keyword>stage III multiple myeloma</keyword>
</DOC>